Clinical Trial Update: RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RQC to prevent Alzheimer's disease and retinal amyloid-β; current status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• RQC

Snippet

Sponsor: Zaparackas and Knepper LTD | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Status: NOT_YET_RECRUITING